Targeting RFWD2 as an Effective Strategy to Inhibit Cellular Proliferation and Overcome Drug Resistance to Proteasome Inhibitor in Multiple Myeloma
Mengjie Guo(Nanjing University of Chinese Medicine), Chunyan Gu(Nanjing University of Chinese Medicine)
Cited by 7
Related Papers
Increased AURKA promotes cell proliferation and predicts poor prognosis in bladder cancer
|BMC Systems Biology|2018|84
CHEK1 and circCHEK1_246aa evoke chromosomal instability and induce bone lesion formation in multiple myeloma
|Molecular Cancer|2021|72
A novel protein encoded by circHNRNPU promotes multiple myeloma progression by regulating the bone marrow microenvironment and alternative splicing
|Journal of Experimental & Clinical Cancer Research|2022|53
Upregulation of FOXM1 leads to diminished drug sensitivity in myeloma
|BMC Cancer|2018|37
AHSA1 is a promising therapeutic target for cellular proliferation and proteasome inhibitor resistance in multiple myeloma
|Journal of Experimental & Clinical Cancer Research|2022|32